Abstract
Myeloid sarcoma (MS) is a tumor consisting of myeloid blasts that occurs at an anatomical site other than the bone marrow. We report the case of a 38-year-old man with duodenal MS who underwent an allogeneic bone marrow transplant in a non-complete remission (CR) state. After the transplant, residual disease was suspected on a fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan, and additional radiotherapy resulted in CR, which has been maintained for 21 months. FDG-PET/CT scanning is useful for evaluating residual myeloid sarcoma during the peritransplant period. © 2012 The Japanese Society of Internal Medicine.
Author supplied keywords
Cite
CITATION STYLE
Yagi, T., Ishikawa, J., Takahashi, M., Yamashita, Y., Kusakabe, S., Yoshinami, T., … Imamura, F. (2012). Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy. Internal Medicine, 51(7), 769–772. https://doi.org/10.2169/internalmedicine.51.6652
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.